IN-VITRO AND IN-VIVO ACTIVITY OF DWC-751, A NEW CEPHALOSPORIN

被引：6

作者：

CHOI, KH

KIM, DJ

SHIM, JS

CHOI, MJ

PARK, NJ

KIM, BO

YU, YH

CHOI, EC

机构：

[1] SEOUL NATL UNIV,COLL PHARM,SEOUL 151742,SOUTH KOREA

[2] DAEWOONG PHARMACEUT CO LTD,CTR RES & DEV,KYONGGI DO 462120,SOUTH KOREA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1994年 / 33卷 / 06期

关键词：

D O I：

10.1093/jac/33.6.1233

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：1233 / 1237

页数：5

共 8 条

[1]

Cleeland R., 1991, ANTIBIOTICS LAB MED, P739

[2]

LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99

[3]

NAGAYAMA A, 1991, CHEMOTHERAPY S1, V39, P513

[4] THE INVITRO ACTIVITY, HUMAN PHARMACOLOGY, AND CLINICAL EFFECTIVENESS OF NEW BETA-LACTAM ANTIBIOTICS [J].

NEU, HC .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1982, 22 :599-642

[5]

OGASHIWA M, 1983, CHEMOTHERAPY S, V31, P1

[6]

SHIROSHI H, 1991, CHEMOTHERAPY S1, V39, P522

[7] INVITRO ACTIVITY OF BAY V3522, A NEW CEPHALOSPORIN, COMPARED WITH ACTIVITIES OF OTHER AGENTS [J].

WISE, R ;

ANDREWS, JM ;

ASHBY, JP ;

THORNBER, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :813-818

[8]

1981, CHEMOTHERAPY-TOKYO, V29, P76

← 1 →